Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders Publication: Federal Register Agency: Federal Motor Carrier Safety Administration Byline: Larry W. Minor Date: 26 December 2023 Subjects: American Government , Driver Licensing |
[Federal Register Volume 88, Number 246 (Tuesday, December 26, 2023)] [Notices] [Pages 89009-89010] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2023-28397] ----------------------------------------------------------------------- DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA-2023-0040] Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department of Transportation (DOT). ACTION: Notice of denials. ----------------------------------------------------------------------- SUMMARY: FMCSA announces its decision to deny applications from 26 individuals who requested an exemption from the Federal Motor Carrier Safety Regulations (FMCSRs) prohibiting persons with a clinical diagnosis of epilepsy or any other condition that is likely to cause a loss of consciousness or any loss of ability to operate a commercial motor vehicle (CMV) from operating CMVs in interstate commerce. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, FMCSA, Department of Transportation, 1200 New Jersey Avenue SE, Washington, DC 20590-0001, (202) 366-4001, fmcsamedical@dot.gov. Office hours are from 8:30 a.m. to 5 p.m. ET Monday through Friday, except Federal holidays. If you have questions regarding viewing material in the docket, contact Dockets Operations, (202) 366-9826. SUPPLEMENTARY INFORMATION: I. Public Participation A. Comments To view comments go to www.regulations.gov. Insert the docket [[Page 89010]] number (FMCSA-2023-0040) in the keyword box, and click ``Search.'' Next, choose the only notice listed, and click ``Browse Comments.'' If you do not have access to the internet, you may view the docket online by visiting Dockets Operations on the ground floor of the DOT West Building, 1200 New Jersey Avenue SE, Washington, DC 20590-0001, between 9 a.m. and 5 p.m. ET Monday through Friday, except Federal holidays. To be sure someone is there to help you, please call (202) 366-9317 or (202) 366-9826 before visiting Dockets Operations. B. Privacy Act In accordance with 49 U.S.C. 31315(b)(6), DOT solicits comments from the public on the exemption request. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov. As described in the system of records notice DOT/ALL 14 (Federal Docket Management System), which can be reviewed at https://www.transportation.gov/individuals/privacy/privacy-act-system-records-notices, the comments are searchable by the name of the submitter. II. Background FMCSA received applications from 26 individuals who requested an exemption from the FMCSRs prohibiting persons with a clinical diagnosis of epilepsy or any other condition that is likely to cause a loss of consciousness or any loss of ability to operate a CMV from operating CMVs in interstate commerce. FMCSA has evaluated the eligibility of these applicants and concluded that granting these exemptions would not provide a level of safety that would be equivalent to, or greater than, the level of safety that would be obtained by complying with Sec. 391.41(b)(8). III. Basis for Exemption Determination Under 49 U.S.C. 31136(e) and 31315(b), FMCSA may grant an exemption from the FMCSRs for no longer than a 5-year period if it finds such exemption would likely achieve a level of safety that is equivalent to, or greater than, the level that would be achieved absent such exemption. The statute also allows the Agency to renew exemptions at the end of the 5-year period. FMCSA grants medical exemptions from the FMCSRs for a 2-year period to align with the maximum duration of a driver's medical certification. The Agency's decision regarding these exemption applications is based on the eligibility criteria, the terms and conditions for Federal exemptions, and an individualized assessment of each applicant's medical information provided by the applicant. IV. Conclusion The Agency has determined that these applicants do not satisfy the eligibility criteria or meet the terms and conditions of the Federal exemption and granting these exemptions would not provide a level of safety that would be equivalent to, or greater than, the level of safety that would be obtained by complying with Sec. 391.41(b)(8). Therefore, the 26 applicants in this notice have been denied exemptions from the physical qualification standards in Sec. 391.41(b)(8). Each applicant has, prior to this notice, received a letter of final disposition regarding his/her exemption request. Those decision letters fully outlined the basis for the denial and constitute final action by the Agency. This notice summarizes the Agency's recent denials as required under 49 U.S.C. 31315(b)(4) by periodically publishing names and reasons for denial. The following 26 applicants do not meet the minimum time requirement for being seizure-free, either on or off of anti-seizure medication: Daniel Ashley (MD) Joseph Bodle (CA) Milverton Burton (FL) Joe Celedonia (MD) Cannon Fowler (AL) Brian Hagen (MN) Tomrone Harris (PA) Andre Hartig (ME) Dylan Hill (KS) Jacob Johnstone (WI) Regan Keller (NH) Richard Kelley (IL) Jeramie Kozlowski (PA) Adam Martin (IN) Dawn McGann (WA) Jaysen Meidell (IL) Douglas Pelton (OH) Kevin Pustelak (PA) Nicholas Quairoli (FL) Jesus Reyna (IL) Jennifer Roberts (NM) Quac'era Schaffer (NC) Paritpal Singh (CA) Kristina Walters (IN) Trevor Ward (CO) Penny Witteman (OH) Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2023-28397 Filed 12-22-23; 8:45 am] BILLING CODE 4910-EX-P